(Q44654861)

5 December 2017

title

Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study (English)

1 reference

5 December 2017

Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study (English)

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

1 April 2024

4

Jim Poling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616189

1 April 2024

author name string

Gerardo Gonzalez

1

1 reference

5 December 2017

Kevin Sevarino

2

1 reference

5 December 2017

Mehmet Sofuoglu

3

1 reference

5 December 2017

Alison Oliveto

5

1 reference

5 December 2017

Kishor Gonsai

6

1 reference

5 December 2017

Tony P. George

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616189

1 April 2024

Thomas R. Kosten

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616189

1 April 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

5 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1360-0443.2003.00544.x

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1360-0443.2003.00544.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

1 April 2024

1 reference

5 December 2017

volume

98

1 reference

5 December 2017

issue

11

1 reference

5 December 2017

page(s)

1625-1632

1 reference

Gabapentin in the treatment of cocaine dependence: a case series.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2003.00544.X

Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2003.00544.X

Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Tiagabine: efficacy and safety in adjunctive treatment of partial seizures

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment

1 April 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

A novel strategy for the treatment of cocaine addiction

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Tiagabine in clinical practice

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Gamma-vinyl gamma-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine/heroin (speedball) challenge

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

gamma-aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine.

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine

1 April 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

MIXOR: a computer program for mixed-effects ordinal regression analysis

1 April 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors.

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Long-term safety of tiagabine

1 April 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Nonparametric Estimation from Incomplete Observations

1 April 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Pharmacological treatment of cocaine dependence: a systematic review

1 April 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression.

1 April 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

The Fifth Edition of the Addiction Severity Index

1 April 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system

1 April 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine.

1 April 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Asymptotically Efficient Rank Invariant Test Procedures

1 April 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Gabapentin therapy for cocaine cravings

1 April 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 April 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Gabapentin: pharmacology and its use in pain management.

1 April 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Follow-up of inpatient cocaine withdrawal for cocaine-using methadone patients.

1 April 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Importance of identifying cocaine and alcohol dependent methadone clients.

1 April 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Baclofen and antidepressant--induced antinociception in formalin test: possible GABA(B) mechanism involvement

1 April 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

1 April 2024

Tiagabine

36

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Pharmacology and clinical experience with tiagabine

1 April 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.

1 April 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1360-0443.2003.00544.X

1 April 2024

Identifiers

1 reference

release_56jp6wzs7fab5plbfl4d75tkny

5 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/56jp6wzs7fab5plbfl4d75tkny

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference